McDermott Will & Emery represented Assured Healthcare Partners (AHP) in the transaction. Assured Healthcare Partners (AHP), a New York-based healthcare investment management firm, announced its investment...
Assured Healthcare Partners’ Investment in Prolerity Clinical Research
Blue Sprig’s Acquisition of Trumpet Behavioral Health
McDermott Will & Emery represented MTS-TBH, LLC in the transaction. MTS-TBH, LLC, a portfolio company of private equity company WindRose Heath Investors, LLC, executed its sale...
Alcentra’s Financing The Investment by Falfurrias Capital Partners Into Brainlabs
International law firm McDermott Will & Emery represented Alcentra on its financing of the growth investment by Falfurrias Capital Partners into Brainlabs. Brainlabs is an internationally...
PureTech Scientific’s $137 Million Acquisition of The Chemours Company’s Glycolic Acid Business
McDermott Will & Emery represented Iron Path Capital, while Spilman Thomas & Battle represented Chemours in the transaction. PureTech Scientific announced the acquisition of The Chemours Company’s...
Vytalize Health’s Acquisition of Independent Physician Association of New York
McDermott Will & Emery represented Vytalize Health in the transaction. Vytalize Health, a leading risk-bearing provider enablement platform, announced its acquisition of Independent Physician Association of...
US Fertility’s Acquisition of Ovation Fertility
McDermott Will & Emery represented Amulet Capital Partners and its platform company, US Fertility, in the transaction. US Fertility, a nationwide fertility focused physician practice management...
Amulet Capital Partners’ Acquisition of United Vein & Vascular Centers
McDermott Will & Emery represented Amulet Capital Partners in the transaction. Amulet Capital Partners, a middle-market private equity investment firm focused exclusively on the healthcare sector,...
WindRose Health Investors’ Investment in Third Wave Recovery Systems
McDermott Will & Emery represented WindRose, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Third Wave in the transaction. WindRose Health Investors, LLC, a New...
RoslinCT’s Merger with Lykan Bioscience
Ropes & Gray and Slaughter & May acted as legal advisors to GHO, while McDermott Will & Emery LLP advised WindRose Health Investors, LLC. RoslinCT entered into...
WindRose’s Investment in RevHealth
McDermott Will & Emery LLP acted as legal advisor to WindRose, while DLA Piper LLP acted as legal advisor to RevHealth. WindRose Health Investors, LLC completed...
Centerline Biomedical’s $33 Million Series B Equity Financing
Centerline Biomedical, Inc., a private medical technology company, closed $33 million Series B equity financing, led by Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical...
Iron Path Capital’s Partnership With Capitol Pain Institute
McDermott Will & Emery represented Iron Path Capital in the transaction. Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, announced its...